EFTRW logo

eFFECTOR Therapeutics, Inc. Warrant


EFTRW: eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).


Show EFTRW Financials

Consumer Interest
SEC Filings

Recent trades of EFTRW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by EFTRW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of EFTRW in WallStreetBets Daily Discussion


Recent insights relating to EFTRW

CNBC Recommendations

Recent picks made for EFTRW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EFTRW

Corporate Flights

Flights by private jets registered to EFTRW